The uPAR System as a Potential Therapeutic Target in the Diseased Eye

Clicks: 482
ID: 117832
2019
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #2 of 84 articles by views in Cells

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Dysregulation of vascular networks is characteristic of eye diseases associated with retinal cell degeneration and visual loss. Visual impairment is also the consequence of photoreceptor degeneration in inherited eye diseases with a major inflammatory component, but without angiogenic profile. Among …
Reference Key
m2019cellsthe Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Cammalleri M;Dal Monte M;Pavone V;De Rosa M;Rusciano D;Bagnoli P;;
Journal Cells
Year 2019
DOI
DOI not found
URL
https://www.pubmed.gov/31426601/
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE Mice review animals humans pubmed abstract nih national institutes of health national library of medicine research support non-u.s. gov't Disease Models Animal Rats Sprague-Dawley Inbred BALB C Receptors massimo dal monte neovascularization pathologic / drug therapy* pmid:31426601 pmc6721659 doi:10.3390/cells8080925 maurizio cammalleri paola bagnoli inflammation / drug therapy* urokinase plasminogen activator* / antagonists & inhibitors urokinase plasminogen activator* / physiology retinal diseases* / drug therapy retinal diseases* / metabolism retinal diseases* / pathology urokinase-type plasminogen activator* / antagonists & inhibitors urokinase-type plasminogen activator* / physiology

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.